By Michael Gwarisa Zimbabwe is among five African countries that have started administering the world’s first all-oral treatment for Trypanosoma brucei rhodesiense sleeping sickness—a rare but deadly disease that has long affected communities in East and Southern Africa. The development marks a turning point in the fight against this neglected tropical disease, especially in endemic regions like Zimbabwe, where tsetse fly infestations remain a concern. The new drug, Fexinidazole Winthrop, is now being offered free of charge in specialized treatment centres in Zimbabwe, Malawi, Ethiopia, Tanzania, and Zambia. Its approval…
Read MoreTag: Portugal.
ICASA Honours Dr Matsidiso Moeti
By Michael Gwarisa The Society for AIDS in Africa (SAA) secretariat has awarded the World Health Organisation African Region (WHO-Afro) Director, Dr Matsidio Moeti the prestigious SAA Excellency award. The prize was handed to her during a plenary session at the ongoing International Conference for AIDS and Sexually Transmitted (STIs) in Africa (ICASA) conference running from December 4 to December 9 at the Harare International Conference Centre (HICC). Presenting the award, SAA president, Dr David Parirenyatwa said it was in appreciation for her dedicated years of leadership and a symbol…
Read More